|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ACTA1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr19:51,883,713...51,886,725
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of AKR1B7 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases activity |
ISO |
Flurbiprofen results in decreased activity of AKR1C1 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
decreases activity |
ISO |
Flurbiprofen results in decreased activity of AKR1C2 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
multiple interactions decreases activity |
ISO |
[Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased chemical synthesis of farnesoic acid; [Flurbiprofen results in decreased activity of AKR1C3 protein] which results in increased metabolism of Farnesol |
CTD |
PMID:19010312 PMID:21187079 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
[Flurbiprofen results in increased phosphorylation of and results in increased activity of PSCA protein] which results in increased expression of AKT1 protein; Akt-I-1,2 compound inhibits the reaction [Flurbiprofen results in increased phosphorylation of and results in increased activity of AKT1 protein]; AKT1 protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA]; Flurbiprofen results in increased phosphorylation of and results in increased activity of AKT1 protein |
CTD |
PMID:16949054 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Flurbiprofen binds to ALB protein |
CTD |
PMID:9353694 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh7a1 |
aldehyde dehydrogenase 7 family, member A1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ALDH7A1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
increases expression |
ISO |
Flurbiprofen results in increased expression of ANP32A mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 8:62,829,125...62,864,469
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Anxa1 |
annexin A1 |
increases expression |
ISO |
Flurbiprofen results in increased expression of ANXA1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
increases expression |
ISO |
Flurbiprofen results in increased expression of ANXA3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Apod |
apolipoprotein D |
increases expression |
ISO |
Flurbiprofen results in increased expression of APOD mRNA |
CTD |
PMID:16949054 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apof |
apolipoprotein F |
increases expression |
ISO |
Flurbiprofen results in increased expression of APOF mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
|
|
G |
App |
amyloid beta precursor protein |
affects cleavage decreases secretion multiple interactions |
ISO EXP |
Flurbiprofen affects the cleavage of APP protein Flurbiprofen results in decreased secretion of APP protein alitretinoin inhibits the reaction [Flurbiprofen results in decreased secretion of APP protein]; Flurbiprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of APP protein]; RXRA protein promotes the reaction [Flurbiprofen results in decreased secretion of APP protein] Flurbiprofen inhibits the reaction [APP protein results in increased uptake of Calcium] |
CTD |
PMID:14690522 PMID:17292621 PMID:18648507 PMID:19659691 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ARG1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
decreases activity |
EXP |
Flurbiprofen results in decreased activity of ASIC1 protein |
CTD |
PMID:11588175 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
ISO |
Flurbiprofen results in increased expression of BIRC5 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
ISO |
Flurbiprofen results in increased expression of BNIP3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions |
EXP |
Dinoprostone inhibits the reaction [Flurbiprofen inhibits the reaction [Histamine results in increased secretion of CALCA protein]]; Dinoprostone inhibits the reaction [Flurbiprofen inhibits the reaction [Serotonin results in increased secretion of CALCA protein]]; Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased secretion of CALCA protein]; Flurbiprofen inhibits the reaction [Adenosine Triphosphate promotes the reaction [Protons results in increased secretion of CALCA protein]]; Flurbiprofen inhibits the reaction [CALCA protein results in increased susceptibility to Nitroprusside]; Flurbiprofen inhibits the reaction [Histamine promotes the reaction [[KNG1 protein co-treated with Serotonin] results in increased secretion of CALCA protein]]; Flurbiprofen inhibits the reaction [Histamine results in increased secretion of CALCA protein]; Flurbiprofen inhibits the reaction [Serotonin results in increased secretion of CALCA protein] |
CTD |
PMID:8581270 PMID:11166334 PMID:12044622 PMID:12791437 PMID:14991081 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of CCNB1 protein |
CTD |
PMID:11687965 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
increases expression |
ISO |
Flurbiprofen results in increased expression of CEACAM1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Ces3a |
carboxylesterase 3a |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of CES3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of CITED2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Cmas |
cytidine monophosphate N-acetylneuraminic acid synthetase |
increases expression |
ISO |
Flurbiprofen results in increased expression of CMAS mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 4:175,718,808...175,737,128
Ensembl chr 4:175,718,808...175,737,125
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of CMPK2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
|
|
G |
Crisp1 |
cysteine-rich secretory protein 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of CRISP1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 9:20,741,775...20,768,796
Ensembl chr 9:20,741,777...20,768,796
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases activity |
ISO EXP |
Flurbiprofen results in decreased activity of CYP17A1 protein |
CTD |
PMID:31184881 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of CYP24A1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions affects hydroxylation increases metabolic processing affects hydrolysis increases hydroxylation affects metabolic processing increases hydrolysis affects binding |
ISO |
3',4'-dimethoxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; 3-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; 4'-methoxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; 5-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; 6,7-dihydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; 7-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; acacetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; alpha-naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; Apigenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; baicalein inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; Benzbromarone inhibits the reaction [CYP2C9 protein polymorphism affects the hydroxylation of Flurbiprofen]; Benzbromarone promotes the reaction [CYP2C9 protein polymorphism affects the hydroxylation of Flurbiprofen]; beta-Naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; chrysin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; Dapsone promotes the reaction [CYP2C9 protein polymorphism results in increased hydroxylation of Flurbiprofen]; Dapsone promotes the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; flavanone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; flavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; Fluconazole affects the reaction [CYP2C9 gene polymorphism affects the metabolism of Flurbiprofen]; galangin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; Genistein inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; kaempferol inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; naringenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; naringin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]; Quercetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] CYP2C9 protein affects the hydroxylation of Flurbiprofen CYP2C9 protein results in increased metabolism of Flurbiprofen CYP2C9 gene polymorphism affects the hydrolysis of Flurbiprofen CYP2C9 protein polymorphism results in increased hydroxylation of Flurbiprofen; CYP2C9 protein results in increased hydroxylation of Flurbiprofen CYP2C9 protein results in increased hydrolysis of Flurbiprofen Flurbiprofen binds to CYP2C9 protein |
CTD |
PMID:9698079 PMID:11901091 PMID:15130760 PMID:15955872 PMID:18378563 PMID:19082874 PMID:21053930 PMID:25775139 More...
|
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
increases expression |
ISO |
Flurbiprofen results in increased expression of CYP2F2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:82,416,108...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Defb1 |
defensin beta 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of DEFB1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Egf |
epidermal growth factor |
increases expression |
ISO |
Flurbiprofen results in increased expression of EGF mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases phosphorylation multiple interactions |
ISO |
Flurbiprofen results in increased phosphorylation of EIF4E protein MAPK14 protein promotes the reaction [Flurbiprofen results in increased phosphorylation of EIF4E protein] |
CTD |
PMID:18056468 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Elavl1 |
ELAV like RNA binding protein 1 |
multiple interactions increases expression |
ISO |
ELAVL1 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; Flurbiprofen promotes the reaction [ELAVL1 protein binds to NGFR mRNA] Flurbiprofen results in increased expression of ELAVL1 protein |
CTD |
PMID:18056468 |
|
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
|
|
G |
Eln |
elastin |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ELN mRNA |
CTD |
PMID:16949054 |
|
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of ENPP2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Faah |
fatty acid amide hydrolase |
decreases activity |
EXP |
Flurbiprofen results in decreased activity of FAAH protein |
CTD |
PMID:12751821 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Folr1 |
folate receptor alpha |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of FOLR1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP ISO |
Flurbiprofen inhibits the reaction [Carrageenan results in increased expression of FOS protein]; Flurbiprofen promotes the reaction [Urethane inhibits the reaction [Carrageenan results in increased expression of FOS protein]]; Urethane inhibits the reaction [Flurbiprofen inhibits the reaction [Carrageenan results in increased expression of FOS protein]] Flurbiprofen inhibits the reaction [Arachidonic Acid results in increased expression of FOS mRNA] |
CTD |
PMID:10864209 PMID:11164833 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression multiple interactions |
ISO |
Flurbiprofen results in increased expression of GDF15 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Flurbiprofen results in increased expression of GDF15 protein]; MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein]; NGFR protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein] |
CTD |
PMID:21097678 |
|
NCBI chr16:18,805,312...18,807,893
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of GPX3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
increases expression |
ISO |
Flurbiprofen results in increased expression of GSTO1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [Misonidazole results in increased activity of GUSB protein] |
CTD |
PMID:6696821 |
|
NCBI chr12:26,701,191...26,714,718
Ensembl chr12:26,697,951...26,726,905
|
|
G |
Hells |
helicase, lymphoid specific |
increases expression |
ISO |
Flurbiprofen results in increased expression of HELLS mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
decreases degradation increases expression multiple interactions increases activity |
ISO |
Flurbiprofen results in decreased degradation of HPGD protein Flurbiprofen results in increased expression of HPGD mRNA [[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein Flurbiprofen results in increased activity of HPGD protein |
CTD |
PMID:19501039 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions |
ISO |
HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] |
CTD |
PMID:16949054 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of HSD11B2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
EXP |
Flurbiprofen results in increased expression of ICAM1 protein |
CTD |
PMID:16020654 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of IFIT2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of APP protein] |
CTD |
PMID:19659691 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
Flurbiprofen analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] |
CTD |
PMID:10903797 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il11 |
interleukin 11 |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [IL11 protein results in increased abundance of Calcium]; Flurbiprofen inhibits the reaction [IL11 protein results in increased abundance of Dinoprostone] |
CTD |
PMID:12110441 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
Flurbiprofen inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Flurbiprofen inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]; Flurbiprofen promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA] Flurbiprofen results in increased expression of [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:11112151 PMID:12517972 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Flurbiprofen analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] |
CTD |
PMID:10903797 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kcnn4 |
potassium calcium-activated channel subfamily N member 4 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of KCNN4 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
|
|
G |
Kng2 |
kininogen 2 |
multiple interactions |
EXP |
Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased abundance of Dinoprostone]; Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased secretion of CALCA protein]; Flurbiprofen inhibits the reaction [[Serotonin co-treated with Histamine] promotes the reaction [KNG1 protein results in increased abundance of Dinoprostone]]; Flurbiprofen inhibits the reaction [Histamine promotes the reaction [[KNG1 protein co-treated with Serotonin] results in increased secretion of CALCA protein]] |
CTD |
PMID:11166334 PMID:12791437 |
|
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
|
|
G |
Lgals3 |
galectin 3 |
increases expression |
ISO |
Flurbiprofen results in increased expression of LGALS3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals9 |
galectin 9 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of LGALS9 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
Flurbiprofen inhibits the reaction [LHB protein results in increased chemical synthesis of Androstane-3,17-diol]; Flurbiprofen inhibits the reaction [LHB protein results in increased chemical synthesis of Testosterone] |
CTD |
PMID:31184881 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
decreases expression |
EXP |
Flurbiprofen results in decreased expression of LHCGR mRNA; Flurbiprofen results in decreased expression of LHCGR protein |
CTD |
PMID:31184881 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Lmo7 |
LIM domain 7 |
increases expression |
ISO |
Flurbiprofen results in increased expression of LMO7 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr15:78,567,029...78,769,833
Ensembl chr15:78,567,023...78,769,783
|
|
G |
LOC120100584 |
small proline-rich protein 2I-like |
increases expression |
ISO |
Flurbiprofen results in increased expression of SPRR2A mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 2:177,815,964...177,816,236
Ensembl chr 2:177,815,964...177,816,236
|
|
G |
Lto1 |
LTO1 maturation factor of ABCE1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of LTO1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:200,074,247...200,080,951
Ensembl chr 1:200,074,253...200,088,061
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Flurbiprofen results in decreased phosphorylation of and results in decreased activity of MAPK1 protein |
CTD |
PMID:19501039 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk11 |
mitogen-activated protein kinase 11 |
multiple interactions |
ISO |
MAPK11 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein] |
CTD |
PMID:18056468 |
|
NCBI chr 7:120,218,471...120,225,488
Ensembl chr 7:120,218,478...120,225,395
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein]; MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; MAPK14 protein promotes the reaction [Flurbiprofen results in increased phosphorylation of EIF4E protein] |
CTD |
PMID:18056468 PMID:21097678 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Flurbiprofen results in decreased phosphorylation of and results in decreased activity of MAPK3 protein |
CTD |
PMID:19501039 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
multiple interactions |
ISO |
Flurbiprofen results in increased phosphorylation of and results in increased activity of MAPKAPK2 protein; MAPKAPK2 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein] |
CTD |
PMID:18056468 |
|
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
multiple interactions |
ISO |
MAPKAPK3 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein] |
CTD |
PMID:18056468 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
[[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein; [Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA Flurbiprofen results in decreased expression of MMP9 mRNA |
CTD |
PMID:19501039 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Msmb |
microseminoprotein, beta |
increases expression |
ISO |
Flurbiprofen results in increased expression of MSMB mRNA |
CTD |
PMID:16949054 |
|
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:11099482 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
increases expression |
ISO |
Flurbiprofen results in increased expression of NFKBIZ mRNA |
CTD |
PMID:16949054 |
|
NCBI chr11:44,782,676...44,810,723
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Ngfr |
nerve growth factor receptor |
multiple interactions increases expression |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Flurbiprofen results in increased expression of NGFR mRNA]; ELAVL1 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; Flurbiprofen promotes the reaction [ELAVL1 protein binds to NGFR mRNA]; Flurbiprofen results in increased stability of and results in increased expression of NGFR mRNA; MAPK11 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; MAPK14 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; MAPKAPK2 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; MAPKAPK3 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]; NGFR protein promotes the reaction [Flurbiprofen results in increased expression of GDF15 protein] Flurbiprofen results in increased expression of NGFR mRNA; Flurbiprofen results in increased expression of NGFR protein |
CTD |
PMID:17409433 PMID:17447067 PMID:18056468 PMID:21097678 |
|
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP ISO |
Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] Flurbiprofen results in increased expression of NOS2 mRNA Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 mRNA] which results in increased chemical synthesis of Nitrites]; Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:8528547 PMID:11405284 PMID:16944022 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
ISO |
Flurbiprofen results in increased activity of NQO1 protein |
CTD |
PMID:8572925 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of PAPSS2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
|
|
G |
Pcp4 |
Purkinje cell protein 4 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of PCP4 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
increases expression |
ISO |
Flurbiprofen results in increased expression of PDZK1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
|
|
G |
Penk |
proenkephalin |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of PENK mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
|
|
G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
increases expression |
ISO |
Flurbiprofen results in increased expression of PIK3C3 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr18:21,845,282...21,934,387
Ensembl chr18:21,845,295...21,929,048
|
|
G |
Pla2g4a |
phospholipase A2 group IVA |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [Arachidonic Acid results in increased expression of PLA2G4A mRNA] |
CTD |
PMID:15878913 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Psca |
prostate stem cell antigen |
multiple interactions increases expression |
ISO |
[Flurbiprofen results in increased phosphorylation of and results in increased activity of PSCA protein] which results in increased expression of AKT1 protein; Akt-I-1,2 compound inhibits the reaction [Flurbiprofen results in increased expression of PSCA protein]; AKT1 protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA]; HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] |
CTD |
PMID:16949054 |
|
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases activity |
ISO EXP |
Flurbiprofen results in decreased activity of PTGS1 protein |
CTD |
PMID:9233713 PMID:9258749 PMID:18848576 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases activity decreases degradation increases expression decreases expression |
EXP ISO |
Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA]; Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] Flurbiprofen results in decreased activity of PTGS2 protein Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone] Flurbiprofen results in decreased degradation of PTGS2 protein; Flurbiprofen results in decreased degradation of PTGS2 protein mutant form Flurbiprofen results in decreased activity of PTGS2 protein; Flurbiprofen results in decreased activity of PTGS2 protein mutant form Flurbiprofen results in increased expression of [IL1B protein results in increased expression of PTGS2 protein]; Flurbiprofen results in increased expression of PTGS2 mRNA; Flurbiprofen results in increased expression of PTGS2 protein Flurbiprofen inhibits the reaction [16,16-Dimethylprostaglandin E2 results in increased expression of PTGS2 mRNA]; Flurbiprofen inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone]; Flurbiprofen inhibits the reaction [[Lipopolysaccharides results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone]; Flurbiprofen inhibits the reaction [Arachidonic Acid results in increased expression of PTGS2 mRNA]; Flurbiprofen inhibits the reaction [Dinoprostone results in increased expression of PTGS2 mRNA]; Flurbiprofen inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]; Flurbiprofen promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Flurbiprofen results in increased expression of and results in increased activity of PTGS2 protein Flurbiprofen results in decreased expression of PTGS2 mRNA |
CTD |
PMID:9099957 PMID:9258749 PMID:9321948 PMID:10594327 PMID:11095985 PMID:11099482 PMID:11112151 PMID:11405284 PMID:11687965 PMID:12517972 PMID:15878913 PMID:16949054 PMID:18848576 PMID:19758985 PMID:22245433 More...
|
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
Flurbiprofen inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] Flurbiprofen inhibits the reaction [Zymosan results in increased localization of and results in increased activity of RELA protein] |
CTD |
PMID:11099482 PMID:11291649 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhog |
ras homolog family member G |
increases expression |
ISO |
Flurbiprofen results in increased expression of RHOG mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:156,618,713...156,630,710
Ensembl chr 1:156,615,349...156,631,257
|
|
G |
Rhou |
ras homolog family member U |
increases expression |
ISO |
Flurbiprofen results in increased expression of RHOU mRNA |
CTD |
PMID:16949054 |
|
NCBI chr19:51,641,408...51,651,249
Ensembl chr19:51,641,227...51,650,552
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [alitretinoin binds to RXRA protein]; RXRA protein promotes the reaction [Flurbiprofen results in decreased secretion of APP protein] |
CTD |
PMID:19659691 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sell |
selectin L |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of SELL protein |
CTD |
PMID:12147693 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Smoc2 |
SPARC related modular calcium binding 2 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of SMOC2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of SOX2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 2:117,536,929...117,539,338
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression |
EXP |
Flurbiprofen results in decreased expression of SRD5A1 mRNA; Flurbiprofen results in decreased expression of SRD5A1 protein |
CTD |
PMID:31184881 |
|
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
|
|
G |
Tgoln2 |
trans-golgi network protein 2 |
increases expression |
ISO |
Flurbiprofen results in increased expression of TGOLN2 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
|
|
G |
Thrsp |
thyroid hormone responsive |
multiple interactions |
ISO |
Flurbiprofen inhibits the reaction [Arachidonic Acid results in decreased expression of THRSP mRNA] |
CTD |
PMID:10357836 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression multiple interactions |
ISO |
Flurbiprofen results in increased expression of TIMP1 protein [[Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA] which results in decreased degradation of HPGD protein; [Flurbiprofen results in increased expression of TIMP1 protein] which results in decreased expression of MMP9 mRNA |
CTD |
PMID:19501039 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Flurbiprofen analog promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Flurbiprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of APP protein] |
CTD |
PMID:10903797 PMID:19659691 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases response to substance decreases response to substance increases expression |
ISO |
Flurbiprofen results in increased abundance of and results in increased phosphorylation of TP53 protein TP53 protein results in increased susceptibility to Flurbiprofen TP53 protein mutant form results in decreased susceptibility to Flurbiprofen Flurbiprofen results in increased expression of TP53 protein |
CTD |
PMID:11687965 PMID:15710360 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Twist1 |
twist family bHLH transcription factor 1 |
decreases expression |
ISO |
Flurbiprofen results in decreased expression of TWIST1 mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
|
|
G |
Tyms |
thymidylate synthetase |
increases expression |
ISO |
Flurbiprofen results in increased expression of TYMS mRNA |
CTD |
PMID:16949054 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases glucuronidation |
ISO |
UGT1A3 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15117964 PMID:15843492 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
increases glucuronidation |
ISO |
UGT1A4 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases glucuronidation |
ISO |
UGT1A6 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,747,229...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a8 |
UDP glucuronosyltransferase family 1 member A8 |
increases glucuronidation |
ISO |
UGT1A8 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15117964 |
|
NCBI chr 9:88,727,094...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases glucuronidation |
EXP |
UGT2B1 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:8302279 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
increases glucuronidation |
ISO |
UGT2B7 protein results in increased glucuronidation of Flurbiprofen |
CTD |
PMID:15843492 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
|
G |
Casp1 |
caspase 1 |
decreases expression |
ISO |
nitroflurbiprofen results in decreased expression of CASP1 mRNA |
CTD |
PMID:15081244 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions |
EXP |
nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of CTH mRNA] |
CTD |
PMID:16491094 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] |
CTD |
PMID:16491094 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of MPO protein] |
CTD |
PMID:16491094 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
ISO EXP |
nitroflurbiprofen results in decreased expression of NOS2 mRNA nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:8528547 PMID:15081244 PMID:16491094 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases activity |
ISO EXP |
nitroflurbiprofen inhibits the reaction [TNF protein results in increased activity of RELA protein] nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein] nitroflurbiprofen results in decreased activity of RELA protein |
CTD |
PMID:12716482 PMID:16491094 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
nitroflurbiprofen inhibits the reaction [TNF protein results in increased activity of RELA protein] nitroflurbiprofen inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:12716482 PMID:16491094 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|